Bodal Chemicals Q1: Revenue up 8%, PAT at ₹9.53 crore

Key takeaway for investors

Bodal Chemicals Ltd reported a mixed set of Q1 numbers, with revenue growth supported by a sharp rise in EBITDA, while net profit stayed modest at ₹9.53 crore. Consolidated total revenue for the quarter was around ₹458 crore, translating into an 8% year-on-year increase. EBITDA rose to about ₹52 crore, up 40% year-on-year, and the company reported an EBITDA margin of 11.3%. The performance came alongside divergence across business divisions, with Basic Chemicals and Chlor-alkali growing while Dye Intermediates and Dyestuff declined. Separately, the market is also watching for the next results cycle, as Bodal Chemicals’ Q1 FY27 (April to June 2026) results are expected in July or August 2026.

Quarterly financial snapshot (quarter ended June)

In the company’s quarterly financial table for the quarter ended Jun 25, total revenue was ₹454.20 crore versus ₹421.96 crore in Jun 24. Operating income rose to ₹30.10 crore from ₹17.42 crore in the year-ago quarter. Net income was ₹9.53 crore compared with a loss of ₹1.18 crore in Jun 24, indicating a turnaround in profitability year-on-year. Diluted normalised EPS was ₹0.85 versus ₹0.03 in the same quarter last year. Costs remained elevated, with total operating expense of ₹424.10 crore and other operating expenses of ₹136.08 crore.

EBITDA surge and margin improvement

Alongside the ₹454.20-₹458.25 crore revenue range reported across sources for the quarter, EBITDA was stated at ₹52.00 crore with an 11.3% margin. Another disclosure reported EBITDA at ₹51.66 crore (₹516.60 million) against ₹36.91 crore (₹369.10 million) in the corresponding quarter last year, a 39.9% increase. The quarter’s profitability reflected operating leverage, even as certain product lines saw revenue pressure. Net profit was reported at ₹9.53 crore (₹95.33 million) versus a loss of ₹1.17 crore (₹11.70 million) in the year-ago quarter in one of the summaries. EPS was also reported at ₹0.76 in one release, while the quarterly table showed diluted normalised EPS at ₹0.85.

Segment performance: growth in chemicals, softness in dyes

Bodal’s segment detail showed an uneven revenue trend. Dye Intermediates revenue was ₹150 crore with a 4% year-on-year decline, while Dyestuff revenue was ₹122 crore and fell 10% year-on-year. Basic Chemicals revenue was ₹45 crore, up 15% year-on-year, and Chlor-alkali revenue was ₹84 crore, up 8% year-on-year. A new Benzene Derivatives segment contributed ₹13 crore. These splits highlight that growth was not uniform across the portfolio, even as the company expanded into benzene downstream products.

How expenses moved in the quarter

The quarter-ended Jun 25 table shows total operating expense at ₹424.10 crore. Selling, general and administrative expenses were ₹31.53 crore. Depreciation and amortisation stood at ₹17.51 crore. Net income before taxes was ₹12.52 crore. The same table also indicates a sequential comparison against Mar 26, where total revenue is listed at ₹588.02 crore and net income at ₹32.06 crore, showing that profits and revenue were lower in the Jun quarter than the immediately preceding quarter shown in that dataset.

Stock context: price, valuation, and recent performance

As of July 2026, the stock traded around ₹64 on NSE. The same note pegged Bodal’s market capitalisation at approximately ₹793 crore and trailing P/E at 16.6x. Another datapoint in the provided material said the shares closed at ₹78.99 on May 20, 2026 (NSE) and delivered 44.56% returns over the last six months and 7.03% over the last 12 months. These figures frame how the market has already repriced the stock over different periods, even as the near-term focus remains on quarterly delivery.

What to watch next: Q1 FY27 result timing and estimates

Bodal Chemicals is expected to announce its Q1 FY27 results in July or August 2026, though the date has not been officially announced yet. The company’s board meeting notice for results approval is expected to be published on NSE and BSE filing portals. A estimates table in the provided material projected Q1 FY27 revenue at ₹438-₹505 crore versus a stated Q4 FY26 actual revenue of ₹577 crore. The same estimate set put PAT at ₹13-₹17 crore versus a stated Q4 FY26 profit of ₹31 crore. An analyst tracking range for a 12-month target was also listed at ₹67-₹76, and another line cited an analyst target range of ₹62-₹71.

Recent base quarter: March 2026 reported numbers

For the March 2026 quarter, one section reported consolidated net sales of ₹588.02 crore, up 30.42% year-on-year from ₹450.87 crore in March 2025. Net profit for March 2026 was ₹32.06 crore, up 121.04% year-on-year from ₹14.50 crore in March 2025. EBITDA stood at ₹71.15 crore in March 2026 versus ₹49.60 crore in March 2025, up 43.45%. EPS was stated at ₹2.55 for March 2026 versus ₹1.15 in March 2025. These numbers establish the immediate performance baseline that investors may use when comparing the next reported quarter.

Market impact and why this quarter matters

The key market factor in the Q1 print is the combination of moderate revenue growth with a strong EBITDA jump, which indicates better operating performance than the top-line alone suggests. At the same time, the segment split shows dyes-related lines (Dye Intermediates and Dyestuff) remained under pressure year-on-year, while chemicals-linked lines grew. The company also maintained revenue guidance of ₹1,900 crore and stated an intent to reduce debt by ₹150-₹175 crore, adding a balance-sheet angle that investors typically track through quarterly updates. With the stock trading near ₹64 in July 2026 and valuation metrics like a trailing P/E of 16.6x cited in the material, the next Q1 FY27 update could become an important checkpoint against the ₹438-₹505 crore revenue estimate range.

Key numbers at a glance

Conclusion

Bodal Chemicals’ Q1 results showed 8% year-on-year revenue growth to around ₹458 crore, a sharp EBITDA rise to about ₹52 crore, and a reported net profit of ₹9.53 crore. The quarter also highlighted diverging trends across divisions, with Basic Chemicals and Chlor-alkali growing while dyes-related segments declined. The next near-term catalyst is the company’s Q1 FY27 results, expected in July or August 2026, with the exact date pending an exchange filing for the board meeting.